Vitality Biopharma Appoints Regulatory Advisor for Cannabis-Derived Prodrugs Program

Vitality Biopharma Appoints Regulatory Advisor for Cannabis-Derived Prodrugs Program
Vitality Biopharma has appointed Tracy Rockney, co-founder and chief operating officer at OneSource Regulatory, to the position of senior regulatory advisor. She will be responsible for the regulatory development of the company’s cannabosides-based prodrug candidate VB100 for inflammatory bowel disease (IBD). Based in Los Angeles, Vitality Biopharma is focused on the development of new drugs

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *